In 2023, Karleen M. Oberton earned $393.40K in total compensation at Hologic, including $183.40K salary and $210.00K bonus. Most recently acquired 9,447 shares in Nov 2024. Currently holds stock worth $12.49M. 7+ years at the helm of Hologic.
Compensation History
Annual executive compensation data for Karleen M. Oberton, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$393.40K
Salary
$183.40K
Bonus
$210.00K
Other
$0.00
Salary
$183.40KBoard Justification
The compensation philosophy emphasizes competitive compensation opportunities aligned with company performance and individual performance objectives, supporting long-term stockholder value.
Bonus
$210.00KBoard Justification
The bonus is based on the Company’s performance metrics and individual performance for fiscal year 2023, paid out in cash.
Other Compensation
$0.00Board Justification
No other compensation details were provided in the proxy statement.
Restricted Stock
Board Justification
No stock vested in 2023 as the proxy statement does not provide any details on vested stock for this year.
Performance Metrics
The performance metrics include company financial performance and individual performance objectives.
Karleen M. Oberton
CEO of Hologic
Education
Bachelor's degree in Business Administration
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
July 12, 1978 - 47 years ago
CEO of Hologic for
7 years 4 months (Aug 2018 - Present)
Previous Experience
Corporate Vice President, Finance and Accounting at Hologic, Inc.
Other Hologic CEOs
Holdings
Track Karleen M. Oberton's stock holdings and portfolio value over time.
Total Stock Sold
$12.55M
$12.55M
229,444 HOLX shares
What if they kept their stock?
If Karleen M. Oberton didn't sell their stock, today they would have:
Extra HOLX229,444 shares worth $17.20M.
This is 37.02% and $4.65M more than what they got when they sold the stock.
Insider Trading
Karleen M. Oberton's recent stock transactions, purchases, and sales filed with the SEC.
9,447 shares
HOLX
Nov 7, 2024
Received
23,710 shares
HOLX
Nov 5, 2024
Received
$4.24M
HOLX at $80.56/share
Aug 29, 2024
Sale
$1.12M
HOLX at $75.00/share
Jan 29, 2024
Sale
8,687 shares
HOLX
Nov 14, 2023
Received
4,633 shares
HOLX
Nov 6, 2023
Received
7,565 shares
HOLX
Nov 7, 2022
Received
20,872 shares
HOLX
Nov 1, 2022
Received
$1.05M
HOLX at $72.50/share
Nov 1, 2022
Sale
7,029 shares
HOLX
Nov 8, 2021
Received
Rivals
Compare Karleen M. Oberton with competitor CEOs and industry peers.
Adam Elsesser
CEO of Penumbra
2023 Compensation
Stock
$0.00
Salary
$600.00K
Bonus
$0.00
Other
$1.62K
Total Holdings
$215.94M
Stanley M. Bergman
CEO of Henry Schein
2023 Compensation
Stock
$0.00
Salary
$1.63M
Bonus
$643.65K
Other
$341.74K
Total Holdings
$49.43M
Fred P. Lampropoulos
Founder and CEO of Merit Medical Systems
2023 Compensation
Stock
$2.77M
Salary
$1.89M
Bonus
$1.34M
Other
$8.70K
Total Holdings
$38.99M
Bryan C. Hanson
CEO of Zimmer Biomet Holdings
2023 Compensation
Stock
$0.00
Salary
$1.26M
Bonus
$0.00
Other
$2.91M
Total Holdings
$199.99K